Literature DB >> 25402425

Redundant and cooperative interactions between TLR5 and NLRC4 in protective lung mucosal immunity against Pseudomonas aeruginosa.

Leslie Tolle1, Fu-shin Yu, Melissa A Kovach, Megan N Ballinger, Michael W Newstead, Xianying Zeng, Gabriel Nunez, Theodore J Standiford.   

Abstract

Flagellin is the major structural component of flagella expressed by Pseudomonas aeruginosa (PA) and other bacteria. This protein has been shown to activate the Toll-like receptor TLR5 and the Nod-like receptor Nlrc4/Ipaf, culminating in the expression of innate cytokines and antimicrobial molecules. In this study, we tested the hypothesis that TLR5 and Nlrc4 in combination are required for maximal protective lung innate mucosal immunity against PA. To test this hypothesis, we compared innate immune responses in wild-type (WT) C57B6 mice challenged with PA intratracheally to those observed in mice genetically deficient in TLR5 (TLR5(-/-)) or Nlrc4 (Nlrc4(-/-)) alone or in combination (TLR5/Nlrc4(-/-)). As compared to WT, TLR5(-/-) and Nlrc4(-/-) mice, we observed a significant increase in mortality in TLR5/Nlrc4(-/-) mice, which was associated with a >5,000-fold increase in lung PA colony-forming units and systemic bacterial dissemination. The increased mortality observed in double-deficient mice was not attributable to differences in lung leukocyte influx or lung injury responses. Levels of biologically active IL-1β and IL-18 were reduced in the bronchoalveolar lavage fluid from PA-infected Nlrc4(-/-) and TLR5/Nlrc4(-/-) but not TLR5(-/-) mice, indicating the requirement for Nlrc4-dependent caspase-1 activation. Similarly, decreased production of biologically active IL-1β and activation of caspase-1 was observed in PA-stimulated pulmonary macrophages isolated from Nlrc4(-/-) and TLR5/Nlrc4(-/-) but not TLR5(-/-) mice, whereas the expression of iNOS and the production of NO were significantly reduced in cells from double-mutant but not single-mutant mice. Collectively, our findings indicate that TLR5 and Nlrc4 have both unique and redundant roles in lung antibacterial mucosal immunity, and the absence of both pathogen recognition receptors results in an increase in susceptibility to invasive lung infection.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25402425      PMCID: PMC4348217          DOI: 10.1159/000367790

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  47 in total

1.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2005-02-15       Impact factor: 21.405

2.  Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria.

Authors:  Vincent Feuillet; Samir Medjane; Isabelle Mondor; Olivier Demaria; Philippe P Pagni; Jorge E Galán; Richard A Flavell; Lena Alexopoulou
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-04       Impact factor: 11.205

3.  IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia.

Authors:  T Sawa; D B Corry; M A Gropper; M Ohara; K Kurahashi; J P Wiener-Kronish
Journal:  J Immunol       Date:  1997-09-15       Impact factor: 5.422

4.  Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M.

Authors:  Jane C Deng; Genhong Cheng; Michael W Newstead; Xianying Zeng; Koichi Kobayashi; Richard A Flavell; Theodore J Standiford
Journal:  J Clin Invest       Date:  2006-08-17       Impact factor: 14.808

5.  Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa.

Authors:  Shawn J Skerrett; Christopher B Wilson; H Denny Liggitt; Adeline M Hajjar
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-08-25       Impact factor: 5.464

6.  Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf.

Authors:  Edward A Miao; Celia M Alpuche-Aranda; Monica Dors; April E Clark; Martin W Bader; Samuel I Miller; Alan Aderem
Journal:  Nat Immunol       Date:  2006-04-30       Impact factor: 25.606

7.  Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia.

Authors:  Marin H Kollef; Andrew Shorr; Ying P Tabak; Vikas Gupta; Larry Z Liu; R S Johannes
Journal:  Chest       Date:  2005-12       Impact factor: 9.410

8.  Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes.

Authors:  Jordi Carratalà; Analía Mykietiuk; Núria Fernández-Sabé; Cristina Suárez; Jordi Dorca; Ricard Verdaguer; Frederic Manresa; Francesc Gudiol
Journal:  Arch Intern Med       Date:  2007-07-09

Review 9.  TLR5 and Ipaf: dual sensors of bacterial flagellin in the innate immune system.

Authors:  Edward A Miao; Erica Andersen-Nissen; Sarah E Warren; Alan Aderem
Journal:  Semin Immunopathol       Date:  2007-08-10       Impact factor: 11.759

10.  A conserved surface on Toll-like receptor 5 recognizes bacterial flagellin.

Authors:  Erica Andersen-Nissen; Kelly D Smith; Richard Bonneau; Roland K Strong; Alan Aderem
Journal:  J Exp Med       Date:  2007-02-05       Impact factor: 14.307

View more
  15 in total

Review 1.  Emerging Roles of Inflammasomes in Acute Pneumonia.

Authors:  Sangeetha Ravi Kumar; Sagar Paudel; Laxman Ghimire; Scott Bergeron; Shanshan Cai; Rachel L Zemans; Gregory P Downey; Samithamby Jeyaseelan
Journal:  Am J Respir Crit Care Med       Date:  2018-01-15       Impact factor: 21.405

Review 2.  Lung epithelial cells: therapeutically inducible effectors of antimicrobial defense.

Authors:  M M Leiva-Juárez; J K Kolls; S E Evans
Journal:  Mucosal Immunol       Date:  2017-08-16       Impact factor: 7.313

3.  Inflammasome gene profile is modulated in septic patients, with a greater magnitude in non-survivors.

Authors:  K F Esquerdo; N K Sharma; M K C Brunialti; G L Baggio-Zappia; M Assunção; L C P Azevedo; A T Bafi; R Salomao
Journal:  Clin Exp Immunol       Date:  2017-04-20       Impact factor: 4.330

4.  IL-24 Promotes Pseudomonas aeruginosa Keratitis in C57BL/6 Mouse Corneas.

Authors:  Bing X Ross; Nan Gao; Xinhan Cui; Theodore J Standiford; Jianjiang Xu; Fu-Shin X Yu
Journal:  J Immunol       Date:  2017-03-22       Impact factor: 5.422

Review 5.  NOD-like receptor(s) and host immune responses with Pseudomonas aeruginosa infection.

Authors:  Alaa Alhazmi
Journal:  Inflamm Res       Date:  2018-01-20       Impact factor: 4.575

6.  HSC70 regulates cold-induced caspase-1 hyperactivation by an autoinflammation-causing mutant of cytoplasmic immune receptor NLRC4.

Authors:  Akhouri Kishore Raghawan; Rajashree Ramaswamy; Vegesna Radha; Ghanshyam Swarup
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-09       Impact factor: 11.205

Review 7.  Reassessing the Evolutionary Importance of Inflammasomes.

Authors:  Vivien I Maltez; Edward A Miao
Journal:  J Immunol       Date:  2016-02-01       Impact factor: 5.422

Review 8.  Programmed Cell Death in the Evolutionary Race against Bacterial Virulence Factors.

Authors:  Carolyn A Lacey; Edward A Miao
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-02-03       Impact factor: 10.005

9.  Elevated prostaglandin E2 post-bone marrow transplant mediates interleukin-1β-related lung injury.

Authors:  G J Martínez-Colón; Q M Taylor; C A Wilke; A B Podsiad; B B Moore
Journal:  Mucosal Immunol       Date:  2017-06-07       Impact factor: 7.313

10.  IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis.

Authors:  Rossana G Iannitti; Valerio Napolioni; Vasilis Oikonomou; Antonella De Luca; Claudia Galosi; Marilena Pariano; Cristina Massi-Benedetti; Monica Borghi; Matteo Puccetti; Vincenzina Lucidi; Carla Colombo; Ersilia Fiscarelli; Cornelia Lass-Flörl; Fabio Majo; Lisa Cariani; Maria Russo; Luigi Porcaro; Gabriella Ricciotti; Helmut Ellemunter; Luigi Ratclif; Fernando Maria De Benedictis; Vincenzo Nicola Talesa; Charles A Dinarello; Frank L van de Veerdonk; Luigina Romani
Journal:  Nat Commun       Date:  2016-03-14       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.